What you should know:
1. The guidelines relate to the screening and surveillance of Barrett’s esophagus.
2. Wats3D uses a sampling brush to clear a wider area of sample tissue, which allows for a surgeon to capture “the full thickness of the epithelium,” including submucosa. CDx developed a 3D computer image analysis system that can create a 3D microbiopsy view of the sample.
3. The computer system then uses artificial intelligence to highlight potential abnormalities in the sample for analysis.
“It is our hope that broader use of Wats3D can potentially transform [esophageal cancer] into a preventable disease,” said CDx Diagnostics CEO William Huffnagle. Barrett’s esophagus is a precursor to esophageal cancer.
More articles on surgery centers:
Dr. Nadja West joins Tenet board
Surgical Notes looking for RCM talent with an ASC focus
Surgery Partners’ former finance leader named CFO of behavioral health system: 3 notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.